Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma - contribution to the development of response criteria for relapsed or progressive disease
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F21%3A10413221" target="_blank" >RIV/00064203:_____/21:10413221 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/21:10413221
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=w2Tvru4HUL" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=w2Tvru4HUL</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2967/jnumed.120.247924" target="_blank" >10.2967/jnumed.120.247924</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma - contribution to the development of response criteria for relapsed or progressive disease
Popis výsledku v původním jazyce
Rationale: In first-line treatment of Hodgkin lymphoma (HL) Deauville scores 1-3 define complete metabolic remission. Interim FDG-PET is also used for relapse treatment adaptation, however PET-response criteria are not validated for relapse treatment. Methods: We performed a pairwise comparative analysis of early treatment response to first-line and to second-line treatment in 127 patients with classical Hodgkin lymphoma who experienced relapse. Patients participated in the prospective, multicenter EuroNet-PHL-C1 study. Residual uptake was measured retrospectively using the qPET method, a validated semiautomatic quantitative extension of the Deauville score. Empirical cumulative distribution functions (ECDF) of the qPET values were used to systematically analyze the response to first-line and second-line treatment. Results and Conclusion: Individual patients responded variably to first-line and second line treatment. However, the ECDF of the qPET values from all patients were nearly superimposable. This supports that first-line and second-line treatment in HL do not require different response criteria.
Název v anglickém jazyce
Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma - contribution to the development of response criteria for relapsed or progressive disease
Popis výsledku anglicky
Rationale: In first-line treatment of Hodgkin lymphoma (HL) Deauville scores 1-3 define complete metabolic remission. Interim FDG-PET is also used for relapse treatment adaptation, however PET-response criteria are not validated for relapse treatment. Methods: We performed a pairwise comparative analysis of early treatment response to first-line and to second-line treatment in 127 patients with classical Hodgkin lymphoma who experienced relapse. Patients participated in the prospective, multicenter EuroNet-PHL-C1 study. Residual uptake was measured retrospectively using the qPET method, a validated semiautomatic quantitative extension of the Deauville score. Empirical cumulative distribution functions (ECDF) of the qPET values were used to systematically analyze the response to first-line and second-line treatment. Results and Conclusion: Individual patients responded variably to first-line and second line treatment. However, the ECDF of the qPET values from all patients were nearly superimposable. This supports that first-line and second-line treatment in HL do not require different response criteria.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30205 - Hematology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Nuclear Medicine
ISSN
0161-5505
e-ISSN
—
Svazek periodika
62
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
4
Strana od-do
338-341
Kód UT WoS článku
000621328300009
EID výsledku v databázi Scopus
2-s2.0-85102217914